Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19671656 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: AMG 162;   Drug: Placebo

Indicates status has not been verified in more than two years